IS MOLECULAR MEDICINE THE FUTURE?
Disease
diagnosis and prognosis has enhanced since a long time. As doctors developed
their understanding of diseases, they recognised measurable signals, or
biomarkers, that show regular biological function, pathology or reaction to
treatment.
In the previous decade, a
new set of technologies have developed that dramatically enhanced the discovery
of new biomarkers. The work promises to reshape how doctors analyze and treat
disease and how pharmaceutical corporations chase drug development. For
instance, in oncology the impacts are already being felt. In the past 18
months, the FDA permitted the first and second tissue-agnostic therapies.
For all the services that are driving the molecular medicine
and diagnostic research forward, others hold it back. Data is often siloed
within administrations or unreachable to the bigger scientific community. It is
also often collected with few morals in mind, so researchers cannot blend data
sets.
Comments
Post a Comment